Quick and comprehensive information on psychotropic drugs for children and adolescents.
- Accurate and up-to-date
- Specific to children and adolescents
- Charts and tables help decision-making
- Icons and full color
More about this book
The Clinical Handbook of Psychotropic Drugs for Children and Adolescents is a unique resource to help you make the right choices about psychotropic medications for younger patients. The fifth edition of this widely acclaimed reference has been fully updated and expanded.
- Updated information on psychiatric disorders in children and adolescents
- Unique comparison charts (dosages, side effects, pharmacokinetics, interactions…)that allow you to see at a glance which medication is the most suitable for each patient
- Instantly recognizable icons in full color throughout, allowing you to quickly find all the information you seek: – General information on medications, availability, and indications
- Clearly written patient and caregiver information sheets as printable pdf files
– Drug action, dosing, pharmacokinetics, and related areas
– Warnings and precautions
– Patient-related information, such as lab monitoring recommendations, nursing implications, and patient advice
This book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.
New in this edition:
- New chapters on Prescribing Safely and Ethically to Children and Adolescents, Pharmacogenetic Information for Common Psychotropic Drugs, and Aggression Management in Children and Adolescents
- Neuroscience-based nomenclature added to Product Availability tables
- Antipsychotic-Induced Extrapyramidal Side Effect (EPSE) chapter completely revised, plus new section on monitoring scales for EPSE
- Anxiolytics section on buspirone and benzodiazepine comparison table revised
- Mood Stabilizers chapter extensively revised
- Natural Health Products comprehensively revised
- New Unapproved Treatments revised, including preliminary evidence for cannabidiol and folinic acid for autism spectrum disorder and ketamine for mood disorder
- New agents: deutetrabenazine, ethopropazine, lemborexant, lumateperone, orphenadrine, tetrabenazine, valbenazine, viloxazine
- New formulations and trade names: Austedo, Caplyta, Dayvigo, Drizalma Sprinkle, Elepsia XR, Eprontia, Evekeo ODT, Gocovri, Hetlioz LQ, Ingrezza, Invega Hafyera, Jornay PM, Loreev XR, Lybalvi, Osmolex ER, Oxtellar XR, Parsitan, Perseris, Qelbree, Qudexy XR, Secuado, Spritam, Tyrvaya, Valtoco
From the reviews
“An impressive work that is informative, thorough, and organized as a practical reference for prescribers. [It] not only provides detailed information on psychotropic agents, but also contextualizes pharmacotherapy as part of a multi¬modal treatment approach [and] serves as a clinical guide that extends beyond the confines of psychopharmacology. The clean and color-coded layout ensures ease of reference and an enjoyable reading experience. With its well-organized structure and layout, comprehensive content, and practical insights, it serves as a valuable tool for clinicians dedicated to providing quality care to children and adolescents with psychiatric disorders.”
Paul Slodovnick MD, Latifa Jaafar MD, and Daniel A. Gorman MD, in Journal of the Canadian Academy of Child & Adolescent Psychiatry (July 2024), 33 (2)
“Child & adolescent psychiatrists crave up to date, evidence-based education, accessible at their fingertips, to ensure they are making the best treatment decisions for their patients. The fifth and most recent edition of the Clinical Handbook of Psychotropic Drugs for Children and Adolescents meets this need thoroughly, and with elegance. The online version of the text is easy to navigate, allowing for “at the elbow” advice when in need of a quick reference to assist in making treatment decisions.
Child & adolescent psychiatrists, pharmacists, nursing, learners and providers will undoubtedly enjoy the updated version of the Clinical Handbook of Psychotropic Drugs for Children and Adolescents. The authors have been thoughtful in their revisions, expansions, and updates, fostering improved certainty and confidence for providers and in turn patients and caregivers alike.”
Sabina Abidi MD and Laura Miller PharmD, in Journal of the Canadian Academy of Child & Adolescent Psychiatry (July 2024), 33 (2)
“This book is an invaluable resource tailored to clinicians, pharmacists, and students learning the basics and complexities of psychopharmacology [and] for mental health professionals and caregivers who prescribe, dispense, or administer psychotropic drugs to children and adolescents. As a psychiatric resident, I agree that the book meets the needs of the intended audience.”
Aashna Sahi, MD, Trinity Health Michigan, in Doody’s Reviews (July 2024)
“All clinical trials with drugs […] have limited practical use without an easy means of extracting information rapidly and without error; i.e., practicing physicians need a suitable “database-physician interface” available at the bedside. This handbook can serve as such an interface.
Although it is primarily a handbook for clinicians, others including clinical pharmacists, clinical pharmacologists and all scientists involved in teaching, research, and drug development will regard it as a valuable information source.”
Barrington (Barry) G. Woodcock-Kloberdanz, BSc, PhD, HNC, DHabil, Roedermark, Germany, in International Journal of Clinical Pharmacology & Therapeutics, 2024
Praise for the book
“This book makes dry material more interesting and is pleasing to the eye… An abundance of new and old ideas, even for very savvy clinicians... An excellent purchase.”
M. M. Relja and M. Sachdev in Journal of Child and Adolescent Psychopharmacology
“A ‘must-have’ for those prescribing psychotropic medications in children and adolescents. It remains by far the most user-friendly and comprehensive handbook available for prescribers, teachers, students, and others working or interested in the field of child and adolescent psychopharmacology.”
Pieter Joost van Wattum in Journal of Clinical Psychiatry
“Authoritatively and exhaustively compiles currently available information in a user-friendly form. The aim of the Handbook is to be a source of ‘fast facts’ for the busy clinician...an aim it achieves splendidly.”
M. Gittelman, Editor of International Journal of Mental Health
“If you see children who are placed on psychotropic medications, this book clearly falls into your ‘must-have’ category.”
J. C. Courtney in Child Neuropsychology